Subacute sclerosing panencephalitis overview: Difference between revisions
No edit summary |
|||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Subacute sclerosing panencephalitis}} | {{Subacute sclerosing panencephalitis}} | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
'''Subacute sclerosing panencephalitis''' | '''Subacute sclerosing panencephalitis''' is a rare chronic, progressive [[encephalitis]] that affects primarily children and young adults, caused by defective [[measles virus]] (which can be a result of a mutation of the virus itself). 1 in 100,000 people infected with measles are at risk. SSPE is 'incurable' but the condition can be managed by medication if treatment is started at an early stage. Much of the work on SSPE has been completed by the [[NINDS]]. | ||
==References== | ==References== | ||
{{ | {{Reflist|2}} | ||
[[Category:Needs content]] | |||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Infectious disease]] | [[Category:Infectious disease]] | ||
[[Category:Neurology]] | [[Category:Neurology]] | ||
[[Category:Neurological disorders]] | |||
[[Category:Viral diseases]] | |||
[[Category:Inflammations]] | |||
{{WH}} | |||
{{WS}} | |||
Revision as of 14:37, 14 December 2012
|
Subacute sclerosing panencephalitis Microchapters |
|
Differentiating Subacute sclerosing panencephalitis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Subacute sclerosing panencephalitis overview On the Web |
|
American Roentgen Ray Society Images of Subacute sclerosing panencephalitis overview |
|
Directions to Hospitals Treating Subacute sclerosing panencephalitis |
|
Risk calculators and risk factors for Subacute sclerosing panencephalitis overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Subacute sclerosing panencephalitis is a rare chronic, progressive encephalitis that affects primarily children and young adults, caused by defective measles virus (which can be a result of a mutation of the virus itself). 1 in 100,000 people infected with measles are at risk. SSPE is 'incurable' but the condition can be managed by medication if treatment is started at an early stage. Much of the work on SSPE has been completed by the NINDS.